The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001
AbstractWe perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Under conservative assumptions, our estimates imply that the average annual increase in life expectancy of the entire population resulting from new drug launches is about one week, and that the incremental cost effectiveness ratio (new drug expenditure per person per year divided by the increase in life-years per person per year attributable to new drug launches) is about $6750—far lower than most estimates of the value of a statistical life-year. Copyright Springer Science+Business Media, Inc. 2005
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Springer in its journal International Journal of Health Care Finance and Economics.
Volume (Year): 5 (2005)
Issue (Month): 1 (January)
Contact details of provider:
Web page: http://www.springerlink.com/link.asp?id=106603
life expectancy; longevity; mortality; pharmaceuticals; innovation; cost-effectiveness;
Other versions of this item:
- Frank R. Lichtenberg, 2003. "The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001," NBER Working Papers 9754, National Bureau of Economic Research, Inc.
- I12 - Health, Education, and Welfare - - Health - - - Health Production
- F00 - International Economics - - General - - - General
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Robert C. Feenstra & Matthew D. Shapiro, 2003. "Scanner Data and Price Indexes," NBER Books, National Bureau of Economic Research, Inc, number feen03-1, October.
- Lichtenberg, Frank R, 1996. "Do (More and Better) Drugs Keep People Out of Hospitals?," American Economic Review, American Economic Association, vol. 86(2), pages 384-88, May.
- Liu, Jin-Tan & Hammitt, James K. & Liu, Jin-Long, 1997. "Estimated hedonic wage function and value of life in a developing country," Economics Letters, Elsevier, vol. 57(3), pages 353-358, December.
- William D. Nordhaus, 2002.
"The Health of Nations: The Contribution of Improved Health to Living Standards,"
Cowles Foundation Discussion Papers
1355, Cowles Foundation for Research in Economics, Yale University.
- William D. Nordhaus, 2002. "The Health of Nations: The Contribution of Improved Health to Living Standards," NBER Working Papers 8818, National Bureau of Economic Research, Inc.
- Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
- Francesco Lancia & Giovanni Prarolo, 2012.
"A politico-economic model of aging, technology adoption and growth,"
Journal of Population Economics,
Springer, vol. 25(3), pages 989-1018, July.
- Giovanni Prarolo & Francesco Lancia, 2007. "A Politico-Economic Model of Aging, Technology Adoption and Growth," Working Papers 2007.48, Fondazione Eni Enrico Mattei.
- F. Lancia & G. Prarolo, 2007. "A Politico-Economic Model of Aging, Technology Adoption and Growth," Working Papers 590, Dipartimento Scienze Economiche, Universita' di Bologna.
- Rodrigo R. Soares, 2005.
"Mortality Reductions, Educational Attainment, and Fertility Choice,"
American Economic Review,
American Economic Association, vol. 95(3), pages 580-601, June.
- Rodrigo R. Soares, 2003. "Mortality Reductions, Educational Attainment, and Fertility Choice," Development and Comp Systems 0312006, EconWPA.
- Rodrigo R. Soares, 2004. "Mortality Reductions, Educational Attainment, and Fertility Choice," Econometric Society 2004 North American Winter Meetings 9, Econometric Society.
- Frank R. Lichtenberg, 2004.
"The expanding pharmaceutical arsenal in the war on cancer,"
2004 Meeting Papers
204, Society for Economic Dynamics.
- Frank R. Lichtenberg, 2004. "The Expanding Pharmaceutical Arsenal in the War on Cancer," NBER Working Papers 10328, National Bureau of Economic Research, Inc.
- Rodrigo R. Soares, 2007.
"On the Determinants of Mortality Reductions in the Developing World,"
Population and Development Review,
The Population Council, Inc., vol. 33(2), pages 247-287.
- Rodrigo R. Soares, 2007. "On the Determinants of Mortality Reductions in the Developing World," NBER Working Papers 12837, National Bureau of Economic Research, Inc.
- Rodrigo Reis Soares, 2006. "On the determinants of mortality reductions in the developing world," Textos para discussÃ£o 529, Department of Economics PUC-Rio (Brazil).
- Nebibe Varol & Joan Costa-i-Font & Alistair McGuire, 2010. "Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment?," LSE Research Online Documents on Economics 29972, London School of Economics and Political Science, LSE Library.
- Nebibe Varol & Joan Costa-i-Font & Alistair McGuire, 2011. "Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale," CESifo Working Paper Series 3459, CESifo Group Munich.
- Bergh, Andreas & Nilsson, Therese, 2009.
"Good for Living? On the Relation between Globalization and Life Expectancy,"
Ratio Working Papers
136, The Ratio Institute.
- Bergh, Andreas & Nilsson, Therese, 2009. "Good for living? On the relation between globalization and life expectancy," Working Papers 2009:9, Lund University, Department of Economics.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Guenther Eichhorn) or (Christopher F. Baum).
If references are entirely missing, you can add them using this form.